Tylenol Maker Kenvue’s Share Swap Opens Door for More Investors

It’s a decisive week for investors looking to get involved in Johnson & Johnson’s record split-off of most of its $40 billion stake in Kenvue Inc., the maker of Tylenol and Listerine. #press

https://www.bloomberg.com/news/articles/2023-08-14/j-j-s-kenvue-swap-opens-door-to-arbs-long-bets-and-index-funds?utm_source=press.coop

Reply to this note

Please Login to reply.

Discussion

No replies yet.